Clinical Trial Update: Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive Therapy [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial assesses whether a subanesthetic dose of ketamine combined with propofol during electroconvulsive therapy affects cognitive function…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)
• PROPOFOL (Propofol)

Snippet

Sponsor: First Affiliated Hospital of Chongqing Medical University | Conditions: Depressive Symptoms, Impaired Cognition | Phase 4 | Status: UNKNOWN